EnCharge AI Welcomes Former Qualcomm Executive Don Rosenberg to its Board of Directors and Jonny Morris to Executive Team

EnCharge AI’s team expansion comes on the heels of its oversubscribed funding round, bringing total funding to $45M to support its full-stack AI chipset.

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

MiNK Therapeutics combines its unique, proprietary library of T-cell antigens with ImmunoScape’s cutting-edge platform for rapid discovery of novel T-cell receptors